A research team led by Dr Somnath Mukhopadhyay, Professor Brian Lipworth and Dr Colin Palmer, has found that a specific genetic variant, known as the Arg/Arg-16 variant, causes salmeterol to be ineffective.
Their research shows that while most patients on salmeterol have their asthma well controlled, those with the Arg/Arg-16 variant have almost double the number of asthma attacks compared to those with the other forms of this gene.
Future research will determine if genetic testing for the Arg/Arg 16 variant should be used in deciding routine asthma prescribing. This is a first step in the path to "personalized medicine" where genetic information will lead to the more effective use of drugs.
"It was apparent that some patients with asthma could be failing to respond to inhaled salmeterol, but we have identified a likely cause for this that is linked to this genetic status," said Dr Mukhopadhyay, of the Children’s Asthma and Allergy Research Unit at the University.
"Where this discovery takes us is towards more personalised asthma treatment, where we can identify which medicines can be used or avoided depending on an individual’s genetic profile and we can ensure the best possible treatment."
The Arg/Arg-16 variant genetic status is reasonably common and it is present in around 13% of young people with asthma in Tayside. The Dundee team studied 546 children and adolescents with asthma in Tayside.
The findings follow studies in America where the US Food and Drug Administration, the principal food and drug regulatory organisation in the United States, has previously warned in November 2005 that salmeterol was not effective in certain individuals, especially African Americans, although the genetic status of these individuals was not studied.
Salmeterol is part of a group of drugs known as beta-agonists, and is widely prescribed within the National Health Service to patients with asthma who fail to respond well to inhaled steroids.
There are 5.2 million people in the UK currently receiving various forms of asthma treatment, and an estimated 675,000 within this population carry the Arg/Arg-16 gene variation and therefore may not benefit from salmeterol treatment.
There are other drugs that can be used as alternative treatments in these individuals.
Although genetic testing is not performed through the NHS, it is important to note that the patients who are put on salmeterol should monitor if the medicine is working or not. If asthma is still poorly controlled on salmeterol, then alternatives, rather than additional treatments, may be more useful.
The results are published today by the leading chest medical journal Thorax, published by the British Thoracic Society and the BMJ Publishing Group.
Roddy Isles | alfa
Antibiotic effective against drug-resistant bacteria in pediatric skin infections
17.02.2017 | University of California - San Diego
Tiny magnetic implant offers new drug delivery method
14.02.2017 | University of British Columbia
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
17.02.2017 | Medical Engineering
17.02.2017 | Medical Engineering
17.02.2017 | Health and Medicine